Annual Revenue
$78.12 M
+$58.41 M+296.32%
31 December 2023
Summary:
Editas Medicine annual revenue is currently $78.12 million, with the most recent change of +$58.41 million (+296.32%) on 31 December 2023. During the last 3 years, it has fallen by -$12.61 million (-13.90%). EDIT annual revenue is now -13.90% below its all-time high of $90.73 million, reached on 31 December 2020.EDIT Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$61.00 K
-$452.00 K-88.11%
30 September 2024
Summary:
Editas Medicine quarterly revenue is currently $61.00 thousand, with the most recent change of -$452.00 thousand (-88.11%) on 30 September 2024. Over the past year, it has dropped by -$5.28 million (-98.86%). EDIT quarterly revenue is now -99.90% below its all-time high of $62.84 million, reached on 30 September 2020.EDIT Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$61.76 M
-$5.28 M-7.87%
30 September 2024
Summary:
Editas Medicine TTM revenue is currently $61.76 million, with the most recent change of -$5.28 million (-7.87%) on 30 September 2024. Over the past year, it has increased by +$37.15 million (+150.95%). EDIT TTM revenue is now -32.58% below its all-time high of $91.60 million, reached on 30 September 2020.EDIT TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EDIT Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +296.3% | -98.9% | +150.9% |
| 3 y3 years | -13.9% | -99.0% | +152.1% |
| 5 y5 years | +144.6% | -98.4% | +329.9% |
EDIT Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -13.9% | +296.3% | -99.9% | +45.2% | -20.9% | +219.7% |
| 5 y | 5 years | -13.9% | +296.3% | -99.9% | +45.2% | -32.6% | +329.9% |
| alltime | all time | -13.9% | +4695.8% | -99.9% | +45.2% | -32.6% | >+9999.0% |
Editas Medicine Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $61.00 K(-88.1%) | $61.76 M(-7.9%) |
| June 2024 | - | $513.00 K(-54.8%) | $67.03 M(-3.4%) |
| Mar 2024 | - | $1.14 M(-98.1%) | $69.41 M(-11.2%) |
| Dec 2023 | $78.12 M(+296.3%) | $60.05 M(+1025.4%) | $78.12 M(+217.4%) |
| Sept 2023 | - | $5.34 M(+84.8%) | $24.61 M(+27.4%) |
| June 2023 | - | $2.89 M(-70.7%) | $19.32 M(-15.2%) |
| Mar 2023 | - | $9.85 M(+50.7%) | $22.79 M(+15.6%) |
| Dec 2022 | $19.71 M(-22.8%) | $6.54 M(>+9900.0%) | $19.71 M(-23.1%) |
| Sept 2022 | - | $42.00 K(-99.3%) | $25.64 M(-19.4%) |
| June 2022 | - | $6.36 M(-6.0%) | $31.80 M(+23.2%) |
| Mar 2022 | - | $6.77 M(-45.7%) | $25.82 M(+1.1%) |
| Dec 2021 | $25.54 M(-71.8%) | $12.47 M(+101.2%) | $25.54 M(+4.3%) |
| Sept 2021 | - | $6.20 M(+1535.1%) | $24.49 M(-69.8%) |
| June 2021 | - | $379.00 K(-94.2%) | $81.14 M(-11.3%) |
| Mar 2021 | - | $6.50 M(-43.1%) | $91.51 M(+0.9%) |
| Dec 2020 | $90.73 M(+341.9%) | $11.42 M(-81.8%) | $90.73 M(-0.9%) |
| Sept 2020 | - | $62.84 M(+484.6%) | $91.60 M(+180.9%) |
| June 2020 | - | $10.75 M(+87.8%) | $32.60 M(+34.8%) |
| Mar 2020 | - | $5.72 M(-53.4%) | $24.18 M(+17.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $20.53 M(-35.7%) | $12.28 M(+219.2%) | $20.53 M(+42.9%) |
| Sept 2019 | - | $3.85 M(+65.2%) | $14.37 M(-42.6%) |
| June 2019 | - | $2.33 M(+12.6%) | $25.04 M(-16.8%) |
| Mar 2019 | - | $2.07 M(-66.2%) | $30.08 M(-5.8%) |
| Dec 2018 | $31.94 M(+132.6%) | $6.12 M(-57.9%) | $31.94 M(+8.3%) |
| Sept 2018 | - | $14.52 M(+96.9%) | $29.48 M(+38.8%) |
| June 2018 | - | $7.37 M(+87.7%) | $21.25 M(+25.2%) |
| Mar 2018 | - | $3.93 M(+7.1%) | $16.97 M(+23.6%) |
| Dec 2017 | $13.73 M(+126.8%) | $3.67 M(-41.6%) | $13.73 M(+25.3%) |
| Sept 2017 | - | $6.28 M(+102.8%) | $10.96 M(+94.3%) |
| June 2017 | - | $3.10 M(+354.1%) | $5.64 M(-4.9%) |
| Mar 2017 | - | $682.00 K(-24.1%) | $5.93 M(-2.0%) |
| Dec 2016 | $6.05 M(+271.6%) | $898.00 K(-6.7%) | $6.05 M(+1.8%) |
| Sept 2016 | - | $962.00 K(-71.6%) | $5.95 M(+5.2%) |
| June 2016 | - | $3.39 M(+320.9%) | $5.66 M(+132.3%) |
| Mar 2016 | - | $805.00 K(+1.6%) | $2.43 M(+49.4%) |
| Dec 2015 | $1.63 M | $792.00 K(+18.2%) | $1.63 M(+94.6%) |
| Sept 2015 | - | $670.00 K(+301.2%) | $837.00 K(+401.2%) |
| June 2015 | - | $167.00 K | $167.00 K |
FAQ
- What is Editas Medicine annual revenue?
- What is the all time high annual revenue for Editas Medicine?
- What is Editas Medicine annual revenue year-on-year change?
- What is Editas Medicine quarterly revenue?
- What is the all time high quarterly revenue for Editas Medicine?
- What is Editas Medicine quarterly revenue year-on-year change?
- What is Editas Medicine TTM revenue?
- What is the all time high TTM revenue for Editas Medicine?
- What is Editas Medicine TTM revenue year-on-year change?
What is Editas Medicine annual revenue?
The current annual revenue of EDIT is $78.12 M
What is the all time high annual revenue for Editas Medicine?
Editas Medicine all-time high annual revenue is $90.73 M
What is Editas Medicine annual revenue year-on-year change?
Over the past year, EDIT annual revenue has changed by +$58.41 M (+296.32%)
What is Editas Medicine quarterly revenue?
The current quarterly revenue of EDIT is $61.00 K
What is the all time high quarterly revenue for Editas Medicine?
Editas Medicine all-time high quarterly revenue is $62.84 M
What is Editas Medicine quarterly revenue year-on-year change?
Over the past year, EDIT quarterly revenue has changed by -$5.28 M (-98.86%)
What is Editas Medicine TTM revenue?
The current TTM revenue of EDIT is $61.76 M
What is the all time high TTM revenue for Editas Medicine?
Editas Medicine all-time high TTM revenue is $91.60 M
What is Editas Medicine TTM revenue year-on-year change?
Over the past year, EDIT TTM revenue has changed by +$37.15 M (+150.95%)